UBS AM’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-996,173
Closed -$183M 2797
2021
Q2
$183M Sell
996,173
-71,308
-7% -$13.1M 0.08% 271
2021
Q1
$163M Sell
1,067,481
-208,890
-16% -$31.9M 0.07% 291
2020
Q4
$199M Sell
1,276,371
-316,062
-20% -$49.4M 0.09% 222
2020
Q3
$182M Sell
1,592,433
-60,415
-4% -$6.91M 0.1% 199
2020
Q2
$186M Sell
1,652,848
-273,121
-14% -$30.7M 0.11% 179
2020
Q1
$173M Buy
1,925,969
+26,131
+1% +$2.35M 0.12% 166
2019
Q4
$205M Buy
1,899,838
+226,288
+14% +$24.5M 0.13% 168
2019
Q3
$164M Buy
1,673,550
+109,415
+7% +$10.7M 0.11% 202
2019
Q2
$205M Buy
1,564,135
+100,509
+7% +$13.2M 0.15% 139
2019
Q1
$198M Sell
1,463,626
-192,550
-12% -$26M 0.15% 146
2018
Q4
$161M Sell
1,656,176
-5,414
-0.3% -$527K 0.14% 161
2018
Q3
$231M Buy
1,661,590
+4,848
+0.3% +$674K 0.17% 122
2018
Q2
$206M Sell
1,656,742
-221,218
-12% -$27.5M 0.16% 142
2018
Q1
$209M Buy
1,877,960
+6,412
+0.3% +$715K 0.17% 132
2017
Q4
$224M Buy
1,871,548
+174,606
+10% +$20.9M 0.19% 113
2017
Q3
$238M Buy
1,696,942
+508,327
+43% +$71.3M 0.22% 101
2017
Q2
$145M Buy
1,188,615
+314,515
+36% +$38.3M 0.14% 169
2017
Q1
$106M Sell
874,100
-9,594
-1% -$1.16M 0.11% 216
2016
Q4
$108M Buy
883,694
+111,149
+14% +$13.6M 0.12% 194
2016
Q3
$94.7M Sell
772,545
-96,884
-11% -$11.9M 0.1% 228
2016
Q2
$102M Buy
869,429
+96,667
+13% +$11.3M 0.11% 198
2016
Q1
$108M Sell
772,762
-31,862
-4% -$4.44M 0.12% 176
2015
Q4
$153M Sell
804,624
-112,301
-12% -$21.4M 0.17% 136
2015
Q3
$143M Sell
916,925
-189,476
-17% -$29.6M 0.16% 146
2015
Q2
$200M Buy
1,106,401
+16,818
+2% +$3.04M 0.19% 122
2015
Q1
$189M Buy
1,089,583
+93,407
+9% +$16.2M 0.18% 127
2014
Q4
$184M Sell
996,176
-78,067
-7% -$14.4M 0.18% 135
2014
Q3
$178M Sell
1,074,243
-35,707
-3% -$5.92M 0.18% 129
2014
Q2
$173M Sell
1,109,950
-89,905
-7% -$14M 0.18% 136
2014
Q1
$183M Sell
1,199,855
-219,870
-15% -$33.4M 0.19% 125
2013
Q4
$189M Sell
1,419,725
-127,077
-8% -$16.9M 0.22% 117
2013
Q3
$180M Buy
1,546,802
+568,206
+58% +$66M 0.22% 114
2013
Q2
$90.3M Buy
+978,596
New +$90.3M 0.12% 205